SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Ovarian Cancer Global Clinical Trials Review, H2, 2012 Profiles Players such as Amgen Inc. and Abbott Laboratories

[January 21, 2013]

Research and Markets: Ovarian Cancer Global Clinical Trials Review, H2, 2012 Profiles Players such as Amgen Inc. and Abbott Laboratories

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/j6vl2w/ovarian_cancer) has announced the addition of GlobalData's new report "Ovarian Cancer Global Clinical Trials Review, H2, 2012" to their offering.

The clinical trial report, Ovarian Cancer Global Clinical Trials Review, H2, 2012" provides data on the Ovarian Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ovarian Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for teating Ovarian Cancer.


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner

- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

- Obtain discontinued trial listing for trials across the globe

- Espy the commercial landscape of the major Universities/Institutes/Hospitals or Companies

Companies Mentioned:

Eli Lilly and Company

AstraZeneca PLC

GlaxoSmithKline plc

Sanofi

Merck & Co., Inc.

Genentech, Inc.

Bristol-Myers Squibb Company

Morphotek, Inc.

Telik, Inc.

Johnson & Johnson

Bayer AG

Fresenius Biotech GmbH

Endocyte, Inc.

Hoffmann-La Roche Inc.

Merck KGaA

EntreMed, Inc.

MEI Pharma, Inc.

Unither Pharmaceuticals

For more information visit http://www.researchandmarkets.com/research/j6vl2w/ovarian_cancer

Source (News - Alert): GlobalData


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.